Prevalence of ROS1 rearrangements in non‐small cell lung cancer screening studies
aScreened specimens consisted entirely of resected adenocarcinomas from never‐smokers who were negative for alterations in EGFR, KRAS, HER2, ALK, and BRAF.
bIdentified in cell line.
cScreened specimens consisted of “pan‐negative” adenocarcinomas (negative for alterations in EGFR, KRAS, BRAF, MEK1, HER2, and ALK).
Abbreviations: FISH, fluorescence in situ hybridization; IHC, immunohistochemistry; RT‐PCR, reverse transcription polymerase chain reaction.
Prevalence of ROS1 rearrangements in non‐small cell lung cancer screening studies
aScreened specimens consisted entirely of resected adenocarcinomas from never‐smokers who were negative for alterations in EGFR, KRAS, HER2, ALK, and BRAF.
bIdentified in cell line.
cScreened specimens consisted of “pan‐negative” adenocarcinomas (negative for alterations in EGFR, KRAS, BRAF, MEK1, HER2, and ALK).
Abbreviations: FISH, fluorescence in situ hybridization; IHC, immunohistochemistry; RT‐PCR, reverse transcription polymerase chain reaction.
